stage iva colorectal cancer ajcc v7
Showing 1 - 12 of 12
Metastatic Carcinoma in the Liver, Resectable Mass, Stage IV Colorectal Cancer AJCC v7 Trial in Houston (biological, other,
Completed
- Metastatic Carcinoma in the Liver
- +4 more
- Durvalumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 30, 2023
EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)
Recruiting
- EGFR NP_005219.2:p.S492R
- +7 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Carcinoma Trial in United States (Laboratory
Active, not recruiting
- Metastatic Colon Carcinoma
- +24 more
- Laboratory Biomarker Analysis
- +2 more
-
Corona, California
- +7 more
Oct 26, 2022
BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Tumor Trial in Houston (biological, drug, other)
Active, not recruiting
- BRAF NP_004324.2:p.V600X
- +6 more
- Cetuximab
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in
Recruiting
- Metastatic Colorectal Adenocarcinoma
- +5 more
- Imiquimod
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Aug 26, 2022
Metastatic Colorectal Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Canada,
Active, not recruiting
- Metastatic Colorectal Carcinoma
- +5 more
- Durvalumab
- +2 more
-
Phoenix, Arizona
- +41 more
Jul 16, 2022
Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,
Completed
- Metastatic Carcinoma in the Liver
- +4 more
- Celecoxib
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 25, 2022
Colorectal Adenocarcinoma, RAS Wild Type, Stage IV Colorectal Cancer AJCC v7 Trial in United States (biological, drug, other)
Completed
- Colorectal Adenocarcinoma
- +4 more
- Bevacizumab
- +4 more
-
Scottsdale, Arizona
- +12 more
Jan 27, 2022
Colon Adenocarcinoma, Rectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v7 Trial in United States (Clobetasol Propionate,
Active, not recruiting
- Colon Adenocarcinoma
- +8 more
- Clobetasol Propionate
- +3 more
-
Phoenix, Arizona
- +21 more
Jan 5, 2022
Metastatic Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Refractory Colorectal Carcinoma Trial in United States (drug,
Active, not recruiting
- Metastatic Colorectal Carcinoma
- +5 more
- Atezolizumab
- +4 more
-
Phoenix, Arizona
- +9 more
Jan 5, 2022
Colorectal Adenocarcinoma, Metastatic Cholangiocarcinoma, Metastatic Colorectal Carcinoma Trial in Houston (biological, drug,
Terminated
- Colorectal Adenocarcinoma
- +12 more
- Adoptive Immunotherapy
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Oct 28, 2020
Colorectal Adenocarcinoma, RAS Wild Type, Stage III Colorectal Cancer AJCC v7 Trial in Los Angeles (biological, drug, other)
Terminated
- Colorectal Adenocarcinoma
- +8 more
- Panitumumab
- +6 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Jun 8, 2020